Editorial: Novel perspectives on the NLRP3 inflammasome

Ying Liang; Kuo-Feng Hua

doi:10.3389/fimmu.2023.1211385

Editorial: Novel perspectives on the NLRP3 inflammasome

Front Immunol. 2023 May 12:14:1211385. doi: 10.3389/fimmu.2023.1211385. eCollection 2023.

Authors

Ying Liang¹, Kuo-Feng Hua^{2

3}

Affiliations

¹ Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, United States.
² Department of Biotechnology and Animal Science, National Ilan University, Ilan, Taiwan.
³ Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan.

No abstract available

Keywords: Duchenne muscular dystrophy; NLRP3 inflammasome; bibliometric study; diffuse large B-cell lymphoma; metabolic diseases; radiation therapy.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Cells, Cultured
Inflammasomes*
NLR Family, Pyrin Domain-Containing 3 Protein*

Substances

Inflammasomes
NLR Family, Pyrin Domain-Containing 3 Protein

Grants and funding

This work is supported by the funding from the National Science and Technology Council, Taiwan (MOST 111-2628-B-197-001-MY3).